Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 357

The DOI matches its Crossref record.

Regulation of receptor concentration by homologous hormone. Effect of human growth hormone on its receptor in IM-9 lymphocytes.

Open access
Lesniak, M A, Roth, J·1976·Journal of Biological Chemistry

Abstract

When cultured human lymphocytes of the IM-9 line were exposed to human growth hormone (hGH) at 37 degrees, washed for 2 hours, and incubated with 125I-hGH, the binding of 125I-hGH was reduced. The magnitude of the reduction in binding was dependent on the concentration of growth hormone present as well as the duration of the exposure. As little as 2 X 10(-11) M (0.5 ng/ml) growth hormone had a discernible effect. Growth hormone at 2 X 10(-10) M (5.0 ng/ml), which is a low resting concentration of hormone in vivo and occupies about 20% of the receptors at steady state at 30 degrees, produced a 50% reduction in binding while 20 mg/ml, which occupies about 50% of the receptors under steady state conditions, produced an 80% loss of receptors. Further increases in growth hormone concentration produced little further effect on receptor loss. Thus, the loss of receptors at a given concentration of growth hormone (up to 20 ng/ml) in the preincubation at 37 degrees was greater than the occupancy produced by that concentration of growth hormone receptors under steady state conditions at 30 degrees. Analysis of the data indicated that the decrease in binding of 125I-hGH was due to a loss of receptors per cell without any change in affinity of receptor for hormone or in cell number. The concentration of insulin receptors on these cells was affected by the insulin concentration in the medium, and the concentration of growth hormone receptors was affected by growth hormone, but neither hormone had any effect on the heterologous receptors. Exposure of the cells to cycloheximide (0.1 mM) produced a progressive but smaller loss of growth hormone receptors, and the effect of cycloheximide was additive to the receptor loss induced by growth hormone, suggesting that cycloheximide inhibited synthesis of receptors while growth hormone accelerated loss of receptors. When growth hormone was removed from the medium, receptor concentrations were restored rapidly; half of the loss was restored by 6 to 8 hours and the full complement of receptors was restored by 24 hours following removal of the hormone. If the growth hormone was removed and replaced with cycloheximide, the return of the receptors was delayed until the cycloheximide was removed. Thus restoration of the receptors appeared to require the synthesis of new proteins. These data indicate that in the IM-9 lymphocytes the concentration of growth hormone receptors is very sensitive to regulation by growth hormone and also add further support to the suggestion that hormones in general actively regulate the concentration of their own receptors.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/s0021-9258(17)33403-8

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

No references could be resolved yet.

Research works printed but not linked: 38

  1. Kahn, 1973, J. Biol. Chem., 248, 244, 10.1016/S0021-9258(19)44468-2 · DOI · Paper page
  2. Kahn, 1972, Biochem. Biophys. Res. Commun., 48, 135, 10.1016/0006-291X(72)90354-3 · DOI
  3. Soll, 1974, J. Biol. Chem., 249, 4127, 10.1016/S0021-9258(19)42492-7 · DOI
  4. Soll, 1975, J. Biol. Chem., 250, 4702, 10.1016/S0021-9258(19)41358-6 · DOI
  5. Soll, 1975, J. Clin. Invest., 56, 769, 10.1172/JCI108155 · DOI · Paper page
  6. Archer, 1975, J. Clin. Invest., 55, 166, 10.1172/JCI107907 · DOI · Paper page
  7. Gavin, 1974, Proc. Natl. Acad. Sci. U. S. A., 71, 84, 10.1073/pnas.71.1.84 · DOI · Paper page
  8. Lesniak, 1973, Nature New Biol., 241, 20, 10.1038/newbio241020a0 · doi:10.1038/newbio241020a0
  9. Lesniak, 1974, J. Biol. Chem., 249, 1661, 10.1016/S0021-9258(19)42840-8 · DOI · Paper page
  10. Fahey, 1971, Ann. N. Y. Acad. Sci., 190, 221, 10.1111/j.1749-6632.1971.tb13537.x · DOI
  11. Moore, 1966, Cancer, 19, 713, 10.1002/1097-0142(196605)19:5<713::AID-CNCR2820190518>3.0.CO;2-Y · DOI
  12. Roth, 1975, Methods Enzymol., 37, 223, 10.1016/S0076-6879(75)37018-3 · doi:10.1016/s0076-6879(75)37018-3
  13. Scatchard, 1949, Ann. N. Y. Acad. Sci., 51, 660, 10.1111/j.1749-6632.1949.tb27297.x · DOI · Paper page
  14. Lesniak, 1974, Clin. Res., 22, 343A
  15. Archer, 1973, J. Clin. Endocrinol. Metab., 36, 627, 10.1210/jcem-36-4-627 · DOI
  16. Goldfine, 1973, Biochem. Biophys. Res. Commun., 53, 853, 10.1016/0006-291X(73)90171-X · DOI
  17. Ducharme, 1961, J. Clin. Invest., 40, 243, 10.1172/JCI104250 · doi:10.1172/jci104250
  18. Bar, 1976, Clin. Res., 24, 269A
  19. Hinkle, 1976, Biochemistry, 14, 3845, 10.1021/bi00688a017 · DOI · Paper page
  20. Posner, 1975, Science, 188, 57, 10.1126/science.163493 · doi:10.1126/science.163493
  21. Costlow, 1975, Endocrinology, 96, 79
  22. Richards, 1976, The Biology of Reproduction
  23. Mukherjee, 1975, Proc. Natl. Acad. Sci. U. S. A., 72, 1945, 10.1073/pnas.72.5.1945 · DOI · Paper page
  24. Kebabian, 1975, Proc. Natl. Acad. Sci. U. S. A., 72, 3735, 10.1073/pnas.72.9.3735 · DOI · Paper page
  25. Milgrom, 1973, J. Biol. Chem., 248, 6366, 10.1016/S0021-9258(19)43455-8 · DOI
  26. Cidlowski, 1974, Endocrinology, 95, 1629, 10.1210/endo-95-6-1621 · doi:10.1210/endo-95-6-1621
  27. Mester, 1975, Biochem. J., 146, 617, 10.1042/bj1460617 · DOI
  28. De Meyts, 1976, J. Supramol. Struct., 4, 241, 10.1002/jss.400040211 · doi:10.1002/jss.400040211
  29. Frazier, 1974, J. Biol. Chem., 249, 5513, 10.1016/S0021-9258(20)79758-9 · DOI · Paper page
  30. Limbird, 1975, Biochem. Biophys. Res. Commun., 64, 1160, 10.1016/0006-291X(75)90815-3 · DOI · Paper page
  31. Ranke, 1974, Endocrinology, 94, A-73
  32. Funder, 1976, Recent Progress in Hormone Research, Proceedings of the 1974 Laurentian Hormone Conference, 31, 129
  33. Olefsky, 1975, Metabolism, 24, 517, 10.1016/0026-0495(75)90076-1 · DOI
  34. Zeleznik, 1974, Endocrinology, 95, 818, 10.1210/endo-95-3-818 · DOI · Paper page
  35. Sherman, 1975, Clin. Res., 23, 479A
  36. Sraer, 1974, Endocrinology, 95, 632, 10.1210/endo-95-2-632 · DOI
  37. Chevillott, 1976, Clin. Sci. Mol. Med.
  38. Soloff, 1975, Biochem. Biophys. Res. Commun., 65, 205, 10.1016/S0006-291X(75)80080-5 · DOI · Paper page

Cited by

See all 357

Metadata

Authors
Lesniak, M. A., & Roth, J.
Venue
Journal of Biological Chemistry
Publisher
Elsevier BV
Published
1976-06
Volume
251
Issue
12
Pages
3720-3729
ISSN
0021-9258 (ISSN-L)
OpenAlex
W141312638
Cited by
357
References
0
FWCI
38.67
Type
journal article
Language
en
Open access
hybrid
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Regulation of receptor concentration by homologous hormone. Effect of human growth hormone on its receptor in IM-9 lymphocytes. https://app.cochat.ai/papers/10.1016/s0021-9258(17)33403-8
The paper
Lesniak, M. A., & Roth, J. (1976). Regulation of receptor concentration by homologous hormone. Effect of human growth hormone on its receptor in IM-9 lymphocytes. Journal of Biological Chemistry. https://doi.org/10.1016/s0021-9258(17)33403-8

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.